近5年代表性论文: 1) Z Li, Y Deng, GY Yang. Growth-coupled high throughput selection for directed enzyme evolution. Biotechnology Advances, 2023, 68, 108238 2) X Jin, GY Yang. Pathophysiological roles and applications of glycosphingolipids in the diagnosis and treatment of cancer diseases. Progress in Lipid Research, 2023, 91, 101241 3) Jingjie Jiang, Guangyu Yang*, Fuqiang Ma*. Fluorescence coupling strategies in fluorescence-activated droplet sorting (FADS) for ultrahigh-throughput screening of enzymes, metabolites, and antibodies. Biotechnol Adv, 2023, 66:108173. 4) B He, X Bai, Y Tan, W Xie, Y Feng, GY Yang. Glycosyltransferases: Mining, engineering and applications in biosynthesis of glycosylated plant natural products. Synthetic and Systems Biotechnology. 2022, 7 (1), 602-620 5) X Chen, X Jin, F Huang, J Wang, X Cao, PG Wang, Y Feng, F Jiang, GY Yang*. Design, synthesis and neurite outgrowth activity of novel ganglioside GM1 derivatives by remodeling of the fatty acid moiety. European Journal of Medicinal Chemistry. 2022, 241, 114636 6) X Bai, D Li, F Ma, X Deng, M Luo, Y Feng, G Yang*. Improved thermostability of creatinase from Alcaligenes Faecalis through non-biased phylogenetic consensus-guided mutagenesis. Microbial cell factories, 2020, 19 (1), 1-13 7) Xi Deng, Liuqing Chen, Mohan Hei, Tiangang Liu, Yan Feng, Guang-Yu Yang*. Structure-guided Reshaping of the Acyl Binding Pocket of 'TesA Thioesterase Enhances Octanoic Acid Production in E. Coli, Metab Eng. 2020, 61:24-32. 8) Yumeng Tan, Yong Zhang, Yunbin Han, Hao Liu, Haifeng Chen, Fuqiang Ma, Stephen G Withers, Yan Feng, Guangyu Yang. Directed evolution of an α1,3-fucosyltransferase using a single-cell ultrahigh-throughput screening method. Science Advances, 2019, eaaw8451 9) Fuqiang Ma#, Meng Ting Chung#, Yuan Yao, Robert Nidet, Lap *** Lee, Allen P. Liu, Yan Feng, Katsuo Kurabayashi*, Guang-Yu Yang*. Efficient molecular evolution to generate enantioselective enzymes using a dual-channel microfluidic droplet screening platform. Nature Communications, 2018, 9:1030. (#equal contribution)